Get started
Author

Keith Rubin

OpenAlex ID: A5048781059
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
2017 · Camille Locht, James F. Papin, et al. · The Journal of Infectious Diseases · 92
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
2023 · Cheryl Keech, Vicki E Miller, et al. · The Lancet · 69
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study
2020 · Maja Jahnmatz, Laura Richert, et al. · The Lancet Infectious Diseases · 60
PDF
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans
2020 · Ang Lin, Danijela Apostolovic, et al. · Journal of Clinical Investigation · 58
PDF
The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization
2018 · Keith Rubin, Steven Glazer · Medical Hypotheses · 25
PDF
Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults
2022 · C. Buddy Creech, Natalia Jimenez-Truque, et al. · Vaccine · 23
The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer’s disease
2016 · Keith Rubin, Steven Glazer · Immunobiology · 23
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis
2025 · Diane Gbesemete, Maheshi N Ramasamy, et al. · The Lancet Microbe · 19
PDF
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis
2015 · Keith Rubin, Steven Glazer · Immunobiology · 14
PDF
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
2020 · Marcel Thalen, Anne-Sophie Debrie, et al. · Vaccines · 10
PDF
Neonatal infection with Bordetella pertussis promotes autism-like phenotypes in mice
2024 · Eoin O’Neill, Lucy Curham, et al. · iScience · 7
Potential Role of Bordetella Pertussis in Celiac Disease
2016 · Keith Rubin, Steven Glazer · International Journal of Celiac Disease · 4
PDF
The potential public health benefit of live-attenuated pertussis vaccines
2025 · Camille Locht, Keith Rubin · Expert Opinion on Drug Delivery · 3
PDF
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation
2026 · Alison R. Hill, Diane F. Gbesemete, et al. · npj Vaccines · 2
596. Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study
2025 · Saul N Faust, Javier Céspedes, et al. · Open Forum Infectious Diseases · 2
PDF
1183. Serum Bactericidal Activity Induced by Live Attenuated Pertussis Vaccine BPZE1 is Comparable to Boostrix™
2021 · Cheryl A Keech, Andrew Gorringe, et al. · Open Forum Infectious Diseases · 2
Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1
2026 · Peter Goldstein, Tania Gensale, et al. · Vaccines · 1
Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant
2024 · Yuying Liu, Jasmin Freeborn, et al. · Frontiers in Immunology · 1
PDF
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6–17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial
2026 · Saul N Faust, Javier Céspedes, et al. · The Lancet Infectious Diseases
The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy
2019 · Keith Rubin, Steven Glazer · Frontiers in Cellular and Infection Microbiology
PDF
Works count: 21
Citation count: 410
H-index: 10
I10-index: 10
Year
Topic
Type